instnjctions): The Synaptic Ap Microdialysis Core will serve projects within this PPG to assess dynamic changes in extracellular, or interstitial fluid (ISF), Ap levels in living mice. Microdialysis enables us to measure Ap levels in the context of a living brain with intact neural networks, a functioning blood-brain barrier, and a normal extracellular milieau. This means that studies are performed in a physiologic setting. Having a core facility organize and conduct these studies, particularly for an intricate technique such as microdialysis, ensures experiments and data across all projects can be combined and compared.

Public Health Relevance

Alzheimer's disease is characterized and likely caused by accumulation of the Ap peptide within the bran extracellular space. Understanding how extracellular Ap changes over time will be critical for determining what factors contribute to disease risk as well as for developing therapeutic interventions. Microdialysis enables us to measure how genes, proteins, or behaviors rapidly change the levels of extracellular Ap.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS074969-02
Application #
8467076
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
2
Fiscal Year
2013
Total Cost
$127,584
Indirect Cost
$49,494
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Liu, Chia-Chen; Zhao, Na; Yamaguchi, Yu et al. (2016) Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease. Sci Transl Med 8:332ra44
Fisher, Jonathan R; Wallace, Clare E; Tripoli, Danielle L et al. (2016) Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo. Mol Neurodegener 11:45
Yamazaki, Yu; Baker, Darren J; Tachibana, Masaya et al. (2016) Vascular Cell Senescence Contributes to Blood-Brain Barrier Breakdown. Stroke 47:1068-77
Tachibana, Masaya; Shinohara, Mitsuru; Yamazaki, Yu et al. (2016) Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1. Exp Neurol 277:1-9
Shinohara, Mitsuru; Kanekiyo, Takahisa; Yang, Longyu et al. (2016) APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations. Ann Neurol :
Sakae, Nobutaka; Liu, Chia-Chen; Shinohara, Mitsuru et al. (2016) ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. J Neurosci 36:3848-59
Yuede, Carla M; Lee, Hyo; Restivo, Jessica L et al. (2016) Rapid in vivo measurement of β-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model. J Exp Med 213:677-85
Ju, Yo-El S; Finn, Mary Beth; Sutphen, Courtney L et al. (2016) Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid. Ann Neurol 80:154-9
Shinohara, Mitsuru; Murray, Melissa E; Frank, Ryan D et al. (2016) Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease. Acta Neuropathol 132:225-34
Fu, Yuan; Zhao, Jing; Atagi, Yuka et al. (2016) Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener 11:37

Showing the most recent 10 out of 59 publications